Literature DB >> 27757152

Could it be Quetiapine-induced Peripartum Cardiomyopathy?

Mandeep Kaler1, Rameen Shakur2, Hazel I Learner1, Andrew Deaner2, Richard J Howard1.   

Abstract

Peri-partum Cardiomyopathy (PPCM) is a rare and life threatening complication of pregnancy. There are only two cases registered with the World Health Organization of cases of cardiomyopathy in patients taking Quetiapine. Here we discuss an interesting case of potential Quetiapine induced cardiomyopathy.

Entities:  

Keywords:  Anti-Psychotics; Arrhythimia; Cardiovascular; High-risk pregnancy; Peripartum cardiomyopathy

Year:  2013        PMID： 27757152      PMCID： PMC5052783          DOI： 10.1258/OM.2012.120035

Source DB:  PubMed          Journal:  Obstet Med        ISSN： 1753-495X


  14 in total

1.  Idiopathic myocardial failure in the last trimester of pregnancy and the puerperium.

Authors:  W R MEADOWS
Journal:  Circulation       Date:  1957-06       Impact factor: 29.690

2.  Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.

Authors:  G D Pearson; J C Veille; S Rahimtoola; J Hsia; C M Oakley; J D Hosenpud; A Ansari; K L Baughman
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

Review 3.  Modern antipsychotic drugs: a critical overview.

Authors:  David M Gardner; Ross J Baldessarini; Paul Waraich
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

Review 4.  Peripartum cardiomyopathy: Causes, diagnosis, and treatment.

Authors:  Radhakrishnan Ramaraj; Vincent L Sorrell
Journal:  Cleve Clin J Med       Date:  2009-05       Impact factor: 2.321

5.  Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice.

Authors:  P A Farber; L A Glasgow
Journal:  Am Heart J       Date:  1970-07       Impact factor: 4.749

6.  Natural course of peripartum cardiomyopathy.

Authors:  J G Demakis; S H Rahimtoola; G C Sutton; W R Meadows; P B Szanto; J R Tobin; R M Gunnar
Journal:  Circulation       Date:  1971-12       Impact factor: 29.690

7.  Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.

Authors:  Karen Sliwa; Lori Blauwet; Kemi Tibazarwa; Elena Libhaber; Jan-Peter Smedema; Anthony Becker; John McMurray; Hatice Yamac; Saida Labidi; Ingrid Struman; Ingrid Struhman; Denise Hilfiker-Kleiner
Journal:  Circulation       Date:  2010-03-22       Impact factor: 29.690

8.  Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation.

Authors:  Uri Elkayam; Mohammed W Akhter; Harpreet Singh; Salman Khan; Fahed Bitar; Afshan Hameed; Avraham Shotan
Journal:  Circulation       Date:  2005-04-26       Impact factor: 29.690

Review 9.  Peripartum cardiomyopathy.

Authors:  M B Lampert; R M Lang
Journal:  Am Heart J       Date:  1995-10       Impact factor: 4.749

10.  An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena.

Authors:  Uzoma N Ibebuogu; John W Thornton; Guy L Reed
Journal:  Thromb J       Date:  2007-10-29
View more
  1 in total

1.  Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS.

Authors:  Luyao He; Yimin Yu; Yumei Wei; Jingjing Huang; Yifeng Shen; Huafang Li
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.